Unknown

Dataset Information

Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients.


ABSTRACT:

Background

Topical timolol is widely used for treatment of superficial infantile hemangioma (IH). However, little is known about factors that affect the response to topical timolol treatment.

Objective

This study aimed to investigate the efficacy, safety, and predictive value for good response to topical timolol for IH.

Methods

A retrospective review of medical records and clinical photos of 328 patients with IH treated with topical timolol 0.5% solution was conducted. Serial clinical photographs were compared with those at the initial visit using a 100-mm visual analogue scale (VAS). Treatment response was defined as an improvement of at least 75% from baseline in IH lesions within 12 months of treatment.

Results

Overall, IH patients treated with topical timol

SUBMITTER: Yu DA 

PROVIDER: S-EPMC9561300 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature